Diclofenac
ADVERTISEMENT
- Molecular formula
- C14H11Cl2NO2
- CAS Number
- 15307-86-5
- IUPAC Name
- 3-(3,4-dichlorophenyl)-2H-1,3-benzoxazin-4-one
- Molecular Weight
- 296.15g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.6000g/cm3
- Appearance
- can vary slightly, but it is typically provided in this form for pharmaceutical use. The crystalline nature allows for easy identification under a microscope.
- Synonyms
- 20972-99-0
Identification
Interesting facts
Interesting Facts about 3-(3,4-Dichlorophenyl)-2H-1,3-benzoxazin-4-one
The compound 3-(3,4-dichlorophenyl)-2H-1,3-benzoxazin-4-one, commonly researched for its potential pharmacological properties, belongs to a class of organic compounds that demonstrate remarkable versatility. Here are some intriguing aspects of this compound:
- Structure and Function: This compound contains a benzoxazinone core, which is known for its ability to engage in various chemical reactions, making it significant in organic synthesis.
- Antimicrobial Activity: Studies have indicated that benzoxazinone derivatives can exhibit antimicrobial properties, suggesting possible applications in developing new antibiotics.
- Inhibition of Cancer Cell Growth: Some derivatives, including this compound, have shown promise in inhibiting the proliferation of cancer cells. This opens avenues for research in cancer therapy.
- Role as a Plant Defense Compound: Benzoxazinones play a crucial role in plants as natural defense agents against herbivores and pathogens, highlighting their importance in plant chemistry.
- Pharmacophore Elucidation: This compound is often involved in designing new drug candidates by elucidating its pharmacophoric features, which can lead to the discovery of more effective pharmaceuticals.
As noted by researchers, "Understanding the molecular behavior of such compounds can lead to breakthroughs in medicinal chemistry." With its diverse applications and intriguing properties, 3-(3,4-dichlorophenyl)-2H-1,3-benzoxazin-4-one represents a critical component in the ongoing exploration of novel therapeutic agents.